<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Epstein-Barr virus (EBV) has been shown to be associated with posttransplant <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e>, and T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, in addition to African Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In a retrospective study of 56 consecutive cases of T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, EBV DNA was found by Southern blot and in situ DNA hybridization in 10 (20%) of 50 peripheral T-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, but in none of six cases of T-lymphoblastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Peripheral T-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> containing EBV DNA could be subclassified into three categories according to histology and immunophenotypic studies: (1) T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> of the helper phenotype, five cases </plain></SENT>
<SENT sid="3" pm="."><plain>Two cases had histologic features resembling angioimmunoblastic <z:hpo ids='HP_0002716'>lymphadenopathy</z:hpo> (AILD) </plain></SENT>
<SENT sid="4" pm="."><plain>(2) T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> of the cytotoxic/suppressor phenotype, four cases </plain></SENT>
<SENT sid="5" pm="."><plain>AILD-like features could also be recognized in two cases </plain></SENT>
<SENT sid="6" pm="."><plain>Reed-Sternberg-like giant cells were identified in three cases designated Hodgkin-like T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>(3) Angiocentric T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> or lymphomatoid <z:hpo ids='HP_0002955'>granulomatosis</z:hpo> in one case, initially affecting the skin and nose; no T-cell subset could be defined </plain></SENT>
<SENT sid="8" pm="."><plain>Six of the eight EBV DNA-positive patients tested for serum EBV antibodies had elevated titers of IgG antiviral capsid antigen (greater than 640) and/or early antigen (greater than 10) </plain></SENT>
<SENT sid="9" pm="."><plain>From combined studies of Southern blot hybridization by using EBV termini fragment probe and in situ DNA hybridization, the EBV genomes appeared to be clonotypically proliferated in the neoplastic T cells </plain></SENT>
<SENT sid="10" pm="."><plain>The patients in <z:hpo ids='HP_0000001'>all</z:hpo> three groups usually had prolonged <z:hpo ids='HP_0001945'>fever</z:hpo> preceding the diagnosis, <z:hpo ids='HP_0001433'>hepatosplenomegaly</z:hpo>, an aggressive clinical course, and poor response to chemotherapy; nine died with a median survival of only 8 months </plain></SENT>
<SENT sid="11" pm="."><plain>We propose that these EBV-associated aggressive T-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, like human T-cell <z:hpo ids='HP_0001909'>leukemia</z:hpo>/<z:hpo ids='HP_0002665'>lymphoma</z:hpo> virus-positive T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, have characteristic clinicopathologic features and should be treated as a separate disease entity </plain></SENT>
</text></document>